Allergan Plc. (NYSE:AGN) announced a pair of acquisitions on Tuesday, both of companies developing treatments for liver disease. Allergan changed its dealmaking strategy following the collapse of its planned $ 160 billion merger with Pfizer Inc. Now, the company is focusing on acquiring small and mid-sized assets. The company will hold a conference call Wednesday, September […]
Mergers & Acquisitions – The Cerbat Gem
Tuesday, January 24, 2017
Allergan Announces Pair Of Acquisitions
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment